Recombinant, non-glycosylated bpi protein and uses thereof
AssigneeIncyte Pharamaceuticals, Inc.
InventorsRandal W. Scott, Marian N. Marra
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for preventing endotoxin-associated shock in a subject which comprises administering to the subject an amount of a BPI protein effective to bind to endotoxin so as to prevent endotoxin associated shock in the subject. This invention further provides a method for treating a subject suffering from endotoxin-associated shock which comprises administering to the subject an amount of a BPI protein effective to bind endotoxin so as to treat the subject suffering from endotoxin-associated shock.
Claims30
A substantially homogeneous, biologically active, recombinant non-glycosylated BPI Protein.
Dependencies are inferred from the claim text.